A stunning 40 percent of what we eat is added sugars and refined carbs, says Christopher Gardner, professor of medicine at the Stanford University School of Medicine
FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities
The FDA approves the active pharmaceutical ingredient (semaglutide) for use in specific brand-name products (Ozempic, Wegovy, Rybelsus), but the compounded formulations produced by compounding pharmacies for individual prescriptions operate under a different regulatory framework
While facing these lawsuits, Eli Lilly and Novo Nordisk have initiated legal actions against compounding pharmacies, seen by some as efforts to deflect accountability for the adverse effects, blaming the compounding manufacturers for creating sub-par medications that have caused the side effects
12.18.24 Study shows link between semaglutide use and NAION A December study showed that a once-weekly semaglutide doubles the five-year risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)